Literature DB >> 8349036

Counterregulation during hypoglycemia is directed by widespread brain regions.

R T Frizzell1, E M Jones, S N Davis, D W Biggers, S R Myers, C C Connolly, D W Neal, J B Jaspan, A D Cherrington.   

Abstract

Previous studies have demonstrated the importance of the brain in directing counterregulation during insulin-induced hypoglycemia in dogs. The capability of selective carotid or vertebrobasilar hypoglycemia in triggering counterregulation was assessed in this study using overnight-fasted dogs. Insulin (21 pM.kg-1.min-1) was infused for 3 h to create peripheral hypoglycemia in the presence of 1) selective carotid hypoglycemia (vertebral glucose infusion, n = 5), 2) selective vertebrobasilar hypoglycemia (carotid glucose infusion, n = 5), 3) the absence of brain hypoglycemia (carotid and vertebral glucose infusion, n = 4), or 4) total brain hypoglycemia (no head glucose infusion, n = 5). Glucose was infused via a leg vein as needed in each group to minimize the differences in peripheral glucose levels (2.6 +/- 0.1, 3.0 +/- 0.2, 2.7 +/- 0.1, and 2.5 +/- 0.1 mM, respectively). The humoral responses (cortisol, glucagon, catecholamines, and pancreatic polypeptide) to hypoglycemia were minimally attenuated (< 40%) by selective carotid or vertebrobasilar euglycemia. In addition, the increase in hepatic glucose production, as assessed using [3-3H]glucose, was attenuated by only 41 and 34%, respectively, during selective carotid or vertebrobasilar hypoglycemia. These observations offer support for the hypothesis that more than one center is important in hypoglycemic counterregulation in the dog and that they are located in brain regions supplied by the carotid and vertebrobasilar arteries, because significant counterregulation occurred when hypoglycemia developed in either of these circulations. Counterregulation during hypoglycemia, therefore, is probably directed by widespread brain regions that contain glucose-sensitive neurons such that the sensing sites are redundant.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349036     DOI: 10.2337/diab.42.9.1253

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  30 in total

Review 1.  Neuroendocrine responses to hypoglycemia.

Authors:  Nolawit Tesfaye; Elizabeth R Seaquist
Journal:  Ann N Y Acad Sci       Date:  2010-10-29       Impact factor: 5.691

2.  Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors.

Authors:  Nell Marty; Michel Dallaporta; Marc Foretz; Martine Emery; David Tarussio; Isabelle Bady; Christophe Binnert; Friedrich Beermann; Bernard Thorens
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 3.  Peripheral chemoreceptors: function and plasticity of the carotid body.

Authors:  Prem Kumar; Nanduri R Prabhakar
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

Review 4.  Brain Glucose-Sensing Mechanism and Energy Homeostasis.

Authors:  A J López-Gambero; F Martínez; K Salazar; M Cifuentes; F Nualart
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

Review 5.  Insulin in the brain: there and back again.

Authors:  William A Banks; Joshua B Owen; Michelle A Erickson
Journal:  Pharmacol Ther       Date:  2012-07-17       Impact factor: 12.310

Review 6.  Peripheral and central glucose sensing in hypoglycemic detection.

Authors:  Casey M Donovan; Alan G Watts
Journal:  Physiology (Bethesda)       Date:  2014-09

7.  Glial glucokinase expression in adult and post-natal development of the hypothalamic region.

Authors:  Carola Millán; Fernando Martínez; Christian Cortés-Campos; Isabel Lizama; Maria Jose Yañez; Paula Llanos; Karin Reinicke; Federico Rodríguez; Bruno Peruzzo; Francisco Nualart; Maria Angeles García
Journal:  ASN Neuro       Date:  2010-05-25       Impact factor: 4.146

8.  Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia.

Authors:  W P Borg; M J During; R S Sherwin; M A Borg; M L Brines; G I Shulman
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

9.  Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes.

Authors:  X Fan; Y Ding; S Brown; L Zhou; M Shaw; M C Vella; H Cheng; E C McNay; R S Sherwin; R J McCrimmon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-04-08       Impact factor: 3.619

10.  Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats.

Authors:  Leon S Farhy; Zhongmin Du; Qiang Zeng; Paula P Veldhuis; Michael L Johnson; Kenneth L Brayman; Anthony L McCall
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-24       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.